Lund, Sweden, 2015-03-04 12:18 CET (GLOBE NEWSWIRE) --
EXINI board member, Henrik Perlmutter, has been appointed Chairman of the Board of EXINI Diagnostics AB (publ) until the forthcoming General Meeting on April 27 due to the sick leave of Fredrik Lindgren.
Henrik Perlmutter has served as a member of the board since 2011 and has over 40 years of experience from the life science industry.
For more information, please contact:
Henrik Perlmutter, Chairman of the Board
Phone: +46 70 337 57 67
E-mail: henrik.perlmutter@swipnet.se
Magnus Aurell, CEO
Phone: +46 46 286 54 25
E-mail: magnus.aurell@exini.com
About EXINI Diagnostics AB (publ)
EXINI Diagnostics AB (publ) offers advanced solutions for medical decision support to hospitals worldwide. The system is based on advanced image analysis by artificial intelligence and can make its own interpretation of medical images and provide diagnostic suggestions. In this way the system is used as a decision support for the diagnosing doctor. EXINI is working with products for the diagnosis of some of the most frequent endemic diseases such as cancer, coronary heart disease, dementia and Parkinson's disease. EXINI is listed on the stock market NASDAQ OMX First North and has about 600 shareholders. Consensus acts as Certified Adviser.
________________________________________________________________________
EXINI Diagnostics AB, Ideon Science Park, Scheelevägen 27, SE-223 70 Lund, Sweden
Phone: +46 46 286 54 20, Fax: +46 46 286 54 29, info@exini.com, www.exini.com
